Armata Pharmaceuticals, Inc. Common Stock (ARMP) R&D Expenses & History | Stock Alarm

Demo Sign up Log In

Armata Pharmaceuticals, Inc. Common Stock · R&D Expenses

ARMP R&D Expenses

Latest reported$25.59Mperiod endingJun 30, 2026

ARMP R&D Expenses ($0.00 → $25.59M)

Annual R&D Expenses

High-resolution chart · PNG

ARMP r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Armata Pharmaceuticals, Inc. Common Stock R&D Expenses — Annual fiscal periods (USD)
Period ending	R&D Expenses (USD)
Dec 31, 2025	23,717,000
Dec 31, 2024	34,426,000
Dec 31, 2023	33,770,000
Dec 31, 2022	35,017,000
Dec 31, 2021	20,015,000
Dec 31, 2020	14,444,000
Dec 31, 2019	9,824,000
Dec 31, 2018	4,892,000
Dec 31, 2017	2,881,000
Dec 31, 2016	5,678,000
Dec 31, 2015	3,992,000
Dec 31, 2014	5,805,000
Dec 31, 2013	6,502,000
Dec 31, 2012	1,480,000
Dec 31, 2009	0
Dec 31, 2008	15,183,000
Dec 31, 2007	17,709,000
Dec 31, 2006	14,482,000
Dec 31, 2005	18,199,000
Dec 31, 2004	17,288,000
Dec 31, 2003	17,197,000
Dec 31, 2002	29,389,000
Dec 31, 2001	31,546,000
Dec 31, 2000	19,312,000
Dec 31, 1999	14,300,000
Dec 31, 1998	13,300,000
Dec 31, 1997	13,000,000
Dec 31, 1996	11,500,000
Dec 31, 1995	8,200,000
Dec 31, 1994	6,800,000
Dec 31, 1993	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.